Cryo-EM White Paper

Meet the Challenges of Implementing Cryo-EM Technology

And give your researchers timely access to mission-critical data

If you were spending upwards of $2.6 billion and 12 years on a product that would ultimately fail, wouldn’t you rather know sooner than later? Cut your losses after year 3 and refocus your resources on the next promising idea?

That’s the position in which pharmaceutical companies find themselves. In fact, it’s their business model. The resources needed to take a drug treatment from concept to reality are extraordinary. And if a treatment is not going to work, the researchers need to know. Now.

To learn more about meeting the promises of cryo-EM, download our free white paper. You’ll gain insights on:

A typical cryo-EM workflow and the potential for backlogs

Utilization conflict and how to minimize investment

How Cray’s expertise can net a 60% speed advantage

With our 45 years of experience handling data-centric workflows, Cray’s solutions are pre-configured to speed time to innovation, handle today’s workloads, and scale to meet the data demands of tomorrow.

Explore related resources:

 All fields are required.

May HPE provide you with personalized communications about HPE and select HPE-partner products, services, offers and events?

For more information on how HPE manages, uses and protects your information please refer to HPE Privacy Statement. You can always withdraw or modify your consent to receive marketing communication from HPE. This can be done by using the opt-out and preference mechanism at the bottom of our email marketing communication or by following this link to unsubscribe.

If you have provided your mobile number to receive marketing communications, please note that roaming charges may apply.